Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol for awake neuromodulative system implantation
NL-OMON44659Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine and propofol in chronic pain (2 arms), sponsored by Erasmus MC. Primary endpoint: Overall patient satisfaction. Started Oct 2015; status: active, not recruiting.
02
Drugs
dexmedetomidinepropofol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NL-OMON44659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44659.